Key facts
- Escala Medical’s last known valuation is $23.6M (Jun 2025).
- It has raised $8.2M; the latest was Later Stage VC ($4.5M) in Jun 2025.
- Notable investors include European Innovation Council, Innovation Authority, Trendlines.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Escala Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Escala Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Escala Medical
Developer of a medical device designed for the treatment of pelvic organ prolapse in patients. The company's devices offer a surgery-based repair to fix the vaginal apex to the sacrospinous ligament, enabling medical professionals to apply a nonsurgical, incision-free, and mesh-free repair approach.
- Sector
- Healthcare
- HQ
- Misgav, Israel
- Founded
- 2014
- Employees
- 5
- Website
- escalamedical.com/
- Ownership
- Privately Held (backing)
Escala Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Escala Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Escala Medical in its N-PORT filings yet. We sweep new filings monthly.